{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:10:37Z","timestamp":1790665837541,"version":"4.1.0"},"reference-count":59,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5,1]]},"DOI":"10.1210\/jc.2009-0205","type":"journal-article","created":{"date-parts":[[2009,5,6]],"date-time":"2009-05-06T17:39:00Z","timestamp":1241631540000},"page":"1483-1490","source":"Crossref","is-referenced-by-count":105,"title":["Approach to the Patient with Transplantation-Related Bone Loss"],"prefix":"10.1210","volume":"94","author":[{"given":"Peter R.","family":"Ebeling","sequence":"first","affiliation":[{"name":"Departments of Medicine (Royal Melbourne Hospital\/Western Hospital) and Endocrinology, The University of Melbourne, Western Hospital, Footscray 3011, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041116321967100_R1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/9780470623992.ch61","article-title":"Transplantation osteoporosis","author":"Ebeling","year":"2008","journal-title":"In: Rosen CJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. 7th ed. Chap 61. Washington, DC: American Society for Bone Mineral Research;"},{"key":"2019041116321967100_R2","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1359\/jbmr.040912","article-title":"Management of bone loss after organ transplantation.","volume":"19","author":"Cohen","year":"2004","journal-title":"J Bone Miner Res"},{"key":"2019041116321967100_R3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00198-003-1426-z","article-title":"Osteoporosis after solid organ and bone marrow transplantation.","volume":"14","author":"Cohen","year":"2003","journal-title":"Osteoporos Int"},{"key":"2019041116321967100_R4","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1617::AID-CNCR27>3.0.CO;2-#","article-title":"Endocrine function and bone metabolism 5 years after autologous bone marrow\/blood-derived progenitor cell transplantation.","volume":"79","author":"Keilholz","year":"1997","journal-title":"Cancer"},{"key":"2019041116321967100_R5","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/cncr.10773","article-title":"High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases.","volume":"95","author":"Tauchmanova\u0300","year":"2002","journal-title":"Cancer"},{"key":"2019041116321967100_R6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.bmt.1701586","article-title":"A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin.","volume":"23","author":"Va\u0308lima\u0308ki","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"2019041116321967100_R7","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1210\/jc.2004-2161","article-title":"Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate.","volume":"90","author":"Kananen","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041116321967100_R8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s001980070124","article-title":"Bone loss in long-term survivors after transplantation of hematopoietic stem cells: a prospective study.","volume":"11","author":"Schulte","year":"2000","journal-title":"Osteoporos Int"},{"key":"2019041116321967100_R9","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/j.1523-1755.2000.00394.x","article-title":"Risk factors for hip fracture among patients with end-stage renal disease.","volume":"58","author":"Stehman-Breen","year":"2000","journal-title":"Kidney Int"},{"key":"2019041116321967100_R10","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1523-1755.2000.00178.x","article-title":"Increased risk of hip fracture among patients with end-stage renal disease.","volume":"58","author":"Alem","year":"2000","journal-title":"Kidney Int"},{"key":"2019041116321967100_R11","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1001\/jama.288.23.3014","article-title":"Risk of hip fracture among dialysis and renal transplant recipients.","volume":"288","author":"Ball","year":"2002","journal-title":"JAMA"},{"key":"2019041116321967100_R12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0002-9343(97)00142-3","article-title":"Bone mass, vitamin D deficiency and hyperparathyroidism in congestive heart failure.","volume":"103","author":"Shane","year":"1997","journal-title":"Am J Med"},{"key":"2019041116321967100_R13","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s001980170094","article-title":"Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics.","volume":"12","author":"Monegal","year":"2001","journal-title":"Osteoporos Int"},{"key":"2019041116321967100_R14","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/lt.20466","article-title":"Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study.","volume":"11","author":"Millonig","year":"2005","journal-title":"Liver Transpl"},{"key":"2019041116321967100_R15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00223-001-2028-4","article-title":"High prevalence of osteoporosis in patients with chronic liver disease prior to liver transplantation.","volume":"69","author":"Ninkovic","year":"2001","journal-title":"Calcif Tissue Int"},{"key":"2019041116321967100_R16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1034\/j.1600-6143.2002.020208.x","article-title":"Osteoporosis before lung transplantation: association with low body mass index, but not with underlying disease.","volume":"2","author":"Tschopp","year":"2002","journal-title":"Am J Transplant"},{"key":"2019041116321967100_R17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1210\/endo.131.1.1611989","article-title":"Differential effects of glucocorticoid on recruitment and activity of osteoclasts induced by normal and osteocalcin-deficient bone implanted in rats.","volume":"131","author":"Defranco","year":"1992","journal-title":"Endocrinology"},{"key":"2019041116321967100_R18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.5650110102","article-title":"Post-transplantation bone disease: the role of immunosuppressive agents on the skeleton.","volume":"11","author":"Epstein","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2019041116321967100_R19","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(00)04765-6","article-title":"Osteoporosis after organ transplantation","volume":"357","author":"Ponticelli","year":"2001","journal-title":"Lancet"},{"key":"2019041116321967100_R20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1399-0012.1995.tb00291.x","article-title":"Long-term bone loss after renal transplantation: comparison of immunosuppressive regimens.","volume":"9","author":"McIntyre","year":"1995","journal-title":"Clin Transplant"},{"key":"2019041116321967100_R21","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0041-1345(98)00181-X","article-title":"Rapid trabecular bone loss after cardiac transplantation using FK506 (tacrolimus)-based immunosuppression.","volume":"30","author":"Stempfle","year":"1998","journal-title":"Transplant Proc"},{"key":"2019041116321967100_R22","first-page":"1738","article-title":"Bone loss after orthotopic liver transplantation: FK 506 versus cyclosporine.","volume":"28","author":"Park","year":"1996","journal-title":"Transplant Proc"},{"key":"2019041116321967100_R23","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(00)04766-8","article-title":"Osteoporosis after organ transplantation","volume":"357","author":"Goffin","year":"2001","journal-title":"Lancet"},{"key":"2019041116321967100_R24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF02678145","article-title":"Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A.","volume":"68","author":"Monegal","year":"2001","journal-title":"Calcif Tissue Int"},{"key":"2019041116321967100_R25","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/jcb.21411","article-title":"Rapamycin inhibits osteoblast proliferation and differentiation in MC3T3\u2013E1 cells and primary mouse bone marrow stromal cells.","volume":"103","author":"Singha","year":"2008","journal-title":"J Cell Biochem"},{"key":"2019041116321967100_R26","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1002\/1097-0142(20011101)92:9<2419::AID-CNCR1591>3.0.CO;2-K","article-title":"High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors: a mechanism for post-bone marrow transplantation osteopenia.","volume":"92","author":"Banfi","year":"2001","journal-title":"Cancer"},{"key":"2019041116321967100_R27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1210\/jcem.87.1.8135","article-title":"The effect of bone marrow transplantation on the osteoblastic differentiation of human bone marrow stromal cells.","volume":"87","author":"Lee","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041116321967100_R28","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1210\/en.2003-0273","article-title":"Parathyroid hormone-related peptide interacts with bone morphogenetic protein 2 to increase osteoblastogenesis and decrease adipogenesis in pluripotent C3H10T mesenchymal cells.","volume":"144","author":"Chan","year":"2003","journal-title":"Endocrinology"},{"key":"2019041116321967100_R29","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1359\/jbmr.1999.14.3.342","article-title":"Mechanism of bone loss following allogeneic and autologous hematopoeitic stem cell transplantation.","volume":"14","author":"Ebeling","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2019041116321967100_R30","first-page":"339","article-title":"Bone disease after bone marrow transplantation","author":"Ebeling","year":"2005","journal-title":"In: Compston J, Shane E, eds. Bone disease of organ transplantation. Chap 19. Atlanta: Elsevier, Academic Press;"},{"key":"2019041116321967100_R31","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3346\/jkms.2002.17.6.749","article-title":"The skeletal site-differential changes in bone mineral density following bone marrow transplantation: 3-year prospective study.","volume":"17","author":"Lee","year":"2002","journal-title":"J Korean Med Sci"},{"key":"2019041116321967100_R32","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1046\/j.1365-2141.2003.04303.x","article-title":"Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: long-term follow-up of a prospective study.","volume":"121","author":"Gandhi","year":"2003","journal-title":"Br J Haematol"},{"key":"2019041116321967100_R33","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1210\/jc.2005-1079","article-title":"Is defective osteoblast function responsible for bone loss from the proximal femur despite pamidronate therapy?","volume":"90","author":"Ebeling","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041116321967100_R34","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00198-003-1520-2","article-title":"Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies.","volume":"14","author":"Tauchmanova\u0300","year":"2003","journal-title":"Osteoporos Int"},{"key":"2019041116321967100_R35","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1210\/jc.2004-0509","article-title":"Short-term zoledronic acid treatment increases bone mineral density and marrow clonogenic fibroblast progenitors after allogeneic stem cell transplantation.","volume":"90","author":"Tauchmanova\u0300","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041116321967100_R36","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1210\/jc.2006-0684","article-title":"Pamidronate reduces bone loss after allogeneic stem cell transplantation.","volume":"91","author":"Grigg","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041116321967100_R37","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1445-5994.2006.01154.x","article-title":"Zoledronic acid prevents bone loss after allogeneic haemopoietic stem cell transplantation.","volume":"36","author":"D'Souza","year":"2006","journal-title":"Int Med J"},{"key":"2019041116321967100_R38","doi-asserted-by":"crossref","DOI":"10.1038\/bmt.2008.414","article-title":"Pilot study on the use of zoledronic acid to prevent bone loss in Allo-SCT recipients","author":"Chae","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"2019041116321967100_R39","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000110875","article-title":"Abnormal bone and mineral metabolism in kidney transplant patients\u2014a review.","volume":"28","author":"Sprague","year":"2008","journal-title":"Am J Nephrol"},{"key":"2019041116321967100_R40","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1359\/jbmr.1999.14.3.456","article-title":"Increased risk of fracture in patients receiving solid organ transplants.","volume":"14","author":"Ramsey-Goldman","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2019041116321967100_R41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.semnephrol.2003.08.012","article-title":"Bone disease after kidney transplantation.","volume":"24","author":"Sprague","year":"2004","journal-title":"Sem Nephrol"},{"key":"2019041116321967100_R42","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005015.pub3","article-title":"Interventions for preventing bone disease in kidney transplant recipients","volume-title":"Cochrane Database Syst Rev 2007:CD005015","author":"Palmer","year":"2007"},{"key":"2019041116321967100_R43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11914-005-0021-y","article-title":"Treatment of osteoporosis in chronic kidney disease and end-stage renal disease.","volume":"3","author":"Miller","year":"2005","journal-title":"Curr Osteoporos Rep"},{"key":"2019041116321967100_R44","first-page":"1740","article-title":"Fracture after cardiac transplantation: a prospective longitudinal study.","volume":"81","author":"Shane","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041116321967100_R45","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0140-6736(00)03641-2","article-title":"Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study.","volume":"357","author":"Leidig-Bruckner","year":"2001","journal-title":"Lancet"},{"key":"2019041116321967100_R46","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1359\/jbmr.2000.15.9.1818","article-title":"Effect of calcitriol on bone loss after cardiac or lung transplantation.","volume":"15","author":"Sambrook","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2019041116321967100_R47","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJMoa035617","article-title":"Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation.","volume":"350","author":"Shane","year":"2004","journal-title":"N Engl J Med"},{"key":"2019041116321967100_R48","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/01.tp.0000177645.63999.ca","article-title":"Discontinuing antiresorptive therapy one year after cardiac transplantation: effect on bone density and bone turnover.","volume":"81","author":"Cohen","year":"2006","journal-title":"Transplantation"},{"key":"2019041116321967100_R49","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/01.tp.0000176927.43937.bb","article-title":"Comparison of calcitonin versus calcitonin and resistance exercise as prophylaxis for osteoporosis in heart transplant recipients.","volume":"81","author":"Braith","year":"2006","journal-title":"Transplantation"},{"key":"2019041116321967100_R50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0168-8278(02)00100-9","article-title":"Lack of effect of intravenous pamidronate on fracture incidence and bone mineral density after orthotopic liver transplantation.","volume":"37","author":"Ninkovic","year":"2002","journal-title":"J Hepatol"},{"key":"2019041116321967100_R51","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00296-006-0196-2","article-title":"Pamidronate and osteoporosis prevention in liver transplant recipients.","volume":"27","author":"Pennisi","year":"2007","journal-title":"Rheumatol Int"},{"key":"2019041116321967100_R52","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/S0041-1345(02)03242-6","article-title":"Effect of transplantation on bone: osteoporosis after liver and multivisceral transplantation.","volume":"34","author":"Hommann","year":"2002","journal-title":"Transplant Proc"},{"key":"2019041116321967100_R53","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7326\/0003-4819-144-4-200602210-00005","article-title":"Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial.","volume":"144","author":"Crawford","year":"2006","journal-title":"Ann Intern Med"},{"key":"2019041116321967100_R54","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.transproceed.2006.02.074","article-title":"The prevention of bone fractures after liver transplantation: experience with alendronate treatment.","volume":"38","author":"Atamaz","year":"2006","journal-title":"Transplant Proc"},{"key":"2019041116321967100_R55","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00007890-199907270-00010","article-title":"Bone loss and fracture after lung transplantation.","volume":"68","author":"Shane","year":"1999","journal-title":"Transplantation"},{"key":"2019041116321967100_R56","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1164\/ajrccm.162.3.2002051","article-title":"Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation.","volume":"162","author":"Aris","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2019041116321967100_R57","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S1053-2498(00)00132-7","article-title":"Bone mineral density in lung-transplant recipients before and after graft: prevention of lumbar spine post-transplantation-accelerated bone loss by pamidronate.","volume":"19","author":"Trombetti","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"2019041116321967100_R58","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.healun.2006.11.004","article-title":"Comparison of alendronate vs. alendronate plus mechanical loading as prophylaxis for osteoporosis in lung transplant recipients: a pilot study.","volume":"26","author":"Braith","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"2019041116321967100_R59","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.bone.2006.06.010","article-title":"Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells.","volume":"39","author":"Rickard","year":"2006","journal-title":"Bone"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/94\/5\/1483\/9062208\/jcem1483.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T08:57:20Z","timestamp":1739091440000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/94\/5\/1483\/2597784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,1]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2009-0205","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,1]]}}}